Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.
Tests & Procedures
Glucose Tolerance Test
How is the glucose tolerance test performed, in whom is it ordered, what does it show during and outside pregnancy, and how are the results assessed? A sourced guide.
Brief summary: The glucose tolerance test, often called OGTT, measures how the body handles a defined glucose load over time. It is used especially in the diagnosis of prediabetes, diabetes, and gestational diabetes. The result should not be evaluated as a number alone; how and why the test was performed also matters.
The glucose tolerance test is a diagnostic test used to evaluate how effectively the body processes glucose. In most practical settings, the patient arrives after a fasting period, a fasting blood sample is obtained, a measured glucose solution is consumed, and blood glucose is checked again at specific time points. The basic logic is simple: the test shows not only the fasting value but also how successfully the body returns blood sugar toward normal after a glucose challenge. This feature makes it particularly useful when fasting glucose alone is not sufficient or when post-meal glucose regulation is clinically important. [1][3][5][6][9]
In adults outside pregnancy, the test is commonly used when there is suspicion of prediabetes or diabetes. It can also be informative in people at increased metabolic risk because of obesity, family history, previous borderline blood sugar values, polycystic ovary syndrome, or other risk factors. The Oral Glucose Tolerance Test has been in use for many years and remains valuable because it can detect abnormalities that may be missed by fasting glucose alone. World Health Organization and NIDDK materials emphasize that it is not the first and only test for every patient, but it still plays an important role when used in the right clinical context. [1][3][4][7][8]
Outside pregnancy, the standard OGTT usually begins with a fasting blood sample. A drink containing a defined amount of glucose is then given, and in most standard protocols blood sugar is measured again at the second hour. In some special situations, intermediate time points may also be assessed, but the routine diagnostic approach is generally based on the fasting and 2-hour values. According to MedlinePlus and Mayo Clinic, short-lived nausea, dizziness, sweating, or weakness may occur during the test. This may be more noticeable in people who have more difficulty tolerating the glucose load. Even so, the test is generally considered safe. [5][6][9]
Interpretation of the result varies according to the reason the test was ordered. In non-pregnant adults, values below certain thresholds on a 75-gram OGTT are considered normal, intermediate values may suggest impaired glucose tolerance—that is, prediabetes—and higher values may be clinically meaningful for a diagnosis of diabetes. However, especially when a result is borderline, the number should be interpreted together with the clinical picture and sometimes repeat testing. WHO and NIDDK emphasize that diagnosis should be made in combination with symptoms, risk profile, and other laboratory data. For that reason, a patient should not attempt to make a definite diagnosis from the report alone. [1][3][4][5]
During pregnancy, the glucose tolerance test is approached somewhat differently. Some centers first use a 50-gram glucose challenge screening test; if screening is abnormal, a more detailed OGTT is then performed. Other guidelines prefer a direct 75-gram oral glucose tolerance test. This difference stems from the screening strategy adopted by the institution. ACOG and NIDDK materials make clear that gestational diabetes diagnosis may follow either a one-step or a two-step approach, but that both aim at the same goal: timely identification of gestational diabetes that could pose risk to mother and baby. [2][6][8]
The importance of testing in pregnancy is not limited to the prenatal period. In people found to have gestational diabetes, postpartum blood sugar follow-up also matters because the risk of developing type 2 diabetes later in life is higher in this group. For that reason, some women are advised to undergo OGTT again or to have another appropriate glucose test in the weeks after delivery. This follow-up shows that the attitude of “the pregnancy ended, so the problem ended” is not sufficient. In particular, long-term surveillance of metabolic risk in those with prior gestational diabetes is part of preventive care. [2][4][6]
One of the strengths of the OGTT is that it can identify people whose fasting glucose appears normal but whose blood sugar rises abnormally after a glucose load. For this reason, some experts still consider it highly valuable, especially in higher-risk groups. On the other hand, reviews in PubMed also highlight limitations such as the time required, imperfect reproducibility, and the practical burden on patients. In other words, the test is very useful, but it is not the best or only option in every situation. Which test should be chosen depends on age, pregnancy status, coexisting conditions, prior test results, and the clinical question being asked. [1][7][8][9]
An “abnormal” OGTT result does not mean complications will immediately develop, but it does indicate that metabolic balance requires attention. If prediabetes is identified, the risk of progression may be reduced through nutrition, physical activity, weight management, and, when appropriate, further evaluation. If diabetes is confirmed, treatment planning is individualized. WHO fact sheets on diabetes emphasize that early diagnosis is important in preventing long-term complications involving the eyes, kidneys, nerves, and cardiovascular system. An OGTT result should therefore be viewed not as a frightening label, but as an opportunity for timely intervention. [3][4][7]
One point that is often misunderstood is the belief that “if it is high, I definitely have diabetes” or “if it is normal, I never need follow-up again.” In reality, glucose metabolism can change over time. If risk factors remain—such as excess weight, family history, previous gestational diabetes, polycystic ovary syndrome, or a sedentary lifestyle—re-evaluation may still be needed later. Similarly, testing during acute illness can be misleading. For that reason, the result gains meaning only when combined with personal medical history and physician assessment. Self-interpretation is especially inappropriate in pregnancy or in borderline results. [1][2][4][6]
The glucose tolerance test remains a very valuable diagnostic tool when ordered in the right person and under the right conditions. Its greatest contribution is that it can reveal abnormalities in glucose handling that might be missed if only the fasting value were considered. Even so, it is not a simple yes-no box, but a result that needs to be interpreted within the clinical context. If your result is normal, discuss your follow-up plan according to your risk profile; if it is high, discuss the next step with the clinician who ordered the test. Professional evaluation should not be delayed in situations such as extreme thirst, frequent urination, unexplained weight loss, blurred vision, or failure to complete recommended pregnancy follow-up. [1][2][4][5][6]
Brief safety guidance: A glucose tolerance test result does not replace individualized medical evaluation. If your results are borderline or high—especially if you are pregnant or have symptoms of diabetes—the safest next step is to review them with your doctor and create an appropriate follow-up plan. [1][2][4]
References
- 1.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Diabetes Tests & Diagnosis. 2025. https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis
- 2.NIDDK. Tests & Diagnosis for Gestational Diabetes. 2025. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/gestational/tests-diagnosis
- 3.World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. 2006. https://iris.who.int/bitstream/handle/10665/43588/9241594934_eng.pdf
- 4.World Health Organization. Diabetes. 2024. https://www.who.int/news-room/fact-sheets/detail/diabetes
- 5.MedlinePlus. Glucose tolerance test - non-pregnant. 2025. https://medlineplus.gov/ency/article/003466.htm
- 6.Mayo Clinic. Glucose tolerance test. 2024. https://www.mayoclinic.org/tests-procedures/glucose-tolerance-test/about/pac-20394296
- 7.Jagannathan R, Sevick MA, Fink D, et al. The Oral Glucose Tolerance Test: 100 Years Later. *Reviews in Endocrine and Metabolic Disorders*. 2020. PubMed: https://pubmed.ncbi.nlm.nih.gov/33116727/
- 8.Bogdanet D, O'Shea P, Lyons C, Shafat A, Dunne F. The Oral Glucose Tolerance Test—Is It Time for a Change? *Diabetic Medicine*. 2020. PubMed: https://pubmed.ncbi.nlm.nih.gov/33121014/
- 9.Zubair M, Wang Y. Glucose Tolerance Test. 2025. PubMed: https://pubmed.ncbi.nlm.nih.gov/30422510/
For more detailed information about this topic or to consult with our specialist physiotherapists, please contact us.
Contact Us